Mannose-binding protein gene polymorphism in systemic lupus erythematosus

Arthritis Rheum. 1995 Jan;38(1):110-4. doi: 10.1002/art.1780380117.

Abstract

Objective: To determine whether an allelic form of mannose-binding protein (MBP) incapable of activating complement is associated with susceptibility to systemic lupus erythematosus (SLE).

Methods: MBP allele frequencies were determined by amplification refractory mutation system-polymerase chain reaction in 102 white SLE patients and 136 controls.

Results: The MBP allele that is unable to activate complement was present in 42 SLE patients (41%) and in 41 controls (30%) (P = 0.08, odds ratio [OR] = 1.6, 95% confidence interval [95% CI] 1.0-2.8). The gene frequency of this allele was 0.25 in SLE patients and 0.19 in controls (P = 0.08, OR = 1.5, 95% CI 1.0-2.3).

Conclusion: Our results suggest that this allele of the MBP gene represents a minor risk factor for SLE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Base Sequence
  • Carrier Proteins / genetics*
  • Child
  • Complement System Proteins / deficiency
  • Female
  • Gene Frequency
  • Humans
  • Lupus Erythematosus, Systemic / genetics*
  • Male
  • Mannose-Binding Lectins
  • Middle Aged
  • Molecular Sequence Data
  • Polymorphism, Genetic

Substances

  • Carrier Proteins
  • Mannose-Binding Lectins
  • Complement System Proteins